OMNI Life Science GmbH & Co. KG – Trademark Portfolio
Entity Type: 30
OMNI Life Science GmbH & Co. KG holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CASY.
Karl-Ferdinand-Braun-Str. 2
28359 Bremen
Showing of trademarks Trademarks
Trademark Classifications
OMNI Life Science GmbH & Co. KG's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does OMNI Life Science GmbH & Co. KG have?
OMNI Life Science GmbH & Co. KG has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does OMNI Life Science GmbH & Co. KG file in?
OMNI Life Science GmbH & Co. KG files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 16 (Paper Goods). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are OMNI Life Science GmbH & Co. KG's most well-known trademarks?
OMNI Life Science GmbH & Co. KG's registered trademark portfolio includes well-known marks such as CASY. These are among 1 currently registered trademark in the portfolio.
What is OMNI Life Science GmbH & Co. KG's trademark registration success rate?
OMNI Life Science GmbH & Co. KG has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.